These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23780972)

  • 1. Primary culture of breast cancer: a model system for epithelial-mesenchymal transition and cancer stem cells.
    Nishikata T; Ishikawa M; Matsuyama T; Takamatsu K; Fukuhara T; Konishi Y
    Anticancer Res; 2013 Jul; 33(7):2867-73. PubMed ID: 23780972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of epithelial-mesenchymal transition in primary breast cancer cell culture.
    Minafra L; Bravatà V; Forte GI; Cammarata FP; Gilardi MC; Messa C
    Anticancer Res; 2014 May; 34(5):2173-83. PubMed ID: 24778019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
    Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells.
    Devarajan E; Song YH; Krishnappa S; Alt E
    Int J Cancer; 2012 Sep; 131(5):1023-31. PubMed ID: 22038895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of breast cancer stem cells with fibrous scaffolds.
    Feng S; Duan X; Lo PK; Liu S; Liu X; Chen H; Wang Q
    Integr Biol (Camb); 2013 May; 5(5):768-77. PubMed ID: 23529778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
    Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
    Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
    Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclopamine decreased the expression of Sonic Hedgehog and its downstream genes in colon cancer stem cells.
    Batsaikhan BE; Yoshikawa K; Kurita N; Iwata T; Takasu C; Kashihara H; Shimada M
    Anticancer Res; 2014 Nov; 34(11):6339-44. PubMed ID: 25368233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumourigenicity and radiation resistance of mesenchymal stem cells.
    D'Andrea FP; Horsman MR; Kassem M; Overgaard J; Safwat A
    Acta Oncol; 2012 May; 51(5):669-79. PubMed ID: 22150078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells: an update.
    Iqbal J; Chong PY; Tan PH
    J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
    Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A
    Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.
    Tang KH; Dai YD; Tong M; Chan YP; Kwan PS; Fu L; Qin YR; Tsao SW; Lung HL; Lung ML; Tong DK; Law S; Chan KW; Ma S; Guan XY
    Cancer Res; 2013 Apr; 73(7):2322-32. PubMed ID: 23382045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
    Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
    Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
    Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
    Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.